Retatrutide: The New Weight Loss Heavyweight – TRIUMPH-1 Results, Real Talk on the Hype, and What It Really Means for You

Eli Lilly’s retatrutide just dropped jaw-dropping Phase 3 results in the TRIUMPH-1 trial, with people losing an average of 28% of their body weight – that’s over 70 pounds for many – rivaling bariatric surgery without going under the knife. In this episode, we break down the exciting numbers on this triple-hormone drug, how it stacks up against Ozempic and Mounjaro, and the impressive health perks like better blood pressure and less inflammation. But we don’t sugarcoat it – we also dive into the real limitations, from side effects to who the study actually included, so you get the full picture before the hype train leaves the station